Circadian rhythm of CSF monoamines and hypocretin-1 in restless legs syndrome and Parkinson's disease
Abstract
The symptoms of restless legs syndrome (RLS) have a circadian pattern and central nervous system dopamine has been implicated in the pathogenesis of the condition. We sought to characterize circadian variation in dopamine and related compounds in human cerebro-spinal fluid (CSF). CSF was continuously withdrawn for 22 h from an implanted lumbar intradural catheter and sampled from three patients with RLS, three patients with Parkinson's disease (PD) and three healthy volunteers. Patients had moderate disease severity and took no medications. We assayed CSF dopamine (DA), homovanillic acid (HVA), dihydroxy-phenylacetic acid (DOPAC) and 5-hydroxyindole acetic acid (5-HIAA) from samples every 30 min by reversed-phase HPLC coupled with electrochemical detection. We also measured CSF levels of hypocretin-1 every hour by RIA. The procedure was well-tolerated. One patient ended the study early due to lumbar radicular pain and was not included in the analysis. There were no changes in CSF cell counts or protein levels from the first to the last samples. There was no difference in any of the compounds between groups, so we fit 24-h cosines to examine if the entire group had significant phase consistency. There was a peak for dopamine at 10 a.m. (p<0.025) and for HVA at 2 p.m. (p<0.01), but no evidence of a significant 24-h rhythm for DOPAC, 5-HIAA, the HVA/5-HIAA ratio, or hypocretin-1. These results demonstrate a circadian rhythm for CSF dopamine and HVA concentrations in humans, with higher levels in the daytime than at nighttime. This circadian variation could underlie the symptoms of RLS and sleep-related variation in motor function in PD.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The amplitude of the circadian rhythm of dopamine appears to be highest in the morning around 10am, and that of homovanillic acid in the afternoon around 2pm.
“For example, the amplitude of the circadian rhythm of dopamine appears to be highest in the morning around 10am, and that of homovanillic acid in the afternoon, around 2pm (Poceta et al., 2009).”
From Circadian dysregulation in Parkinson's disease (2017) · cites this paper as Poceta et al., 2009
Cites
Circular Statistics in Biology
Watson, G. S., & Batschelet, E. (1982) · Technometrics · doi:10.2307/1267831 · Cited by 4,632 · see citing works
Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology
Allen, R. P., Picchietti, D., Hening, W. A., Trenkwalder, C., Walters, A. S., & Montplaisi, J. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00010-8 · Cited by 2,900 · see citing works
Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome
Earley, C. J., Connor, J. R., Beard, J. L., Malecki, E. A., Epstein, D. K., & Allen, R. P. (2000) · Neurology · doi:10.1212/wnl.54.8.1698 · Cited by 618 · see citing works
Wong, M., Kling, M. A., Munson, P. J., Listwak, S. J., Licinio, J., Prolo, P., Karp, B., McCutcheon, I. E., Geracioti, T. D., DeBellis, M. D., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.1.325 · Cited by 575 · see citing works
Neurobiology of Cerebrospinal Fluid.
(1981) · Annals of Internal Medicine · doi:10.7326/0003-4819-94-2-291_2 · Cited by 343 · see citing works
CSF iron, ferritin and transferrin levels in restless legs syndrome
Mizuno, S., Mihara, T., Miyaoka, T., INAGAKI, T., & Horiguchi, J. (2005) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2004.00403.x · Cited by 285 · see citing works
Restless Legs Syndrome and Attention-Deficit/Hyperactivity Disorder: a Review of the Literature
Cortese, S., Konofal, É., Lecendreux, M., Arnulf, I., Mouren, M., Darra, F., & Bernardina, B. D. (2005) · SLEEP · doi:10.1093/sleep/28.8.1007 · Cited by 280 · see citing works
An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome
Ruottinen, H., Partinen, M., Hublin, C., Bergman, J., Haaparanta‐Solin, M., Solin, O. H., & Rinne, J. O. (2000) · Neurology · doi:10.1212/wnl.54.2.502 · Cited by 280 · see citing works
Wrong, M. (2000) · Medical Entomology and Zoology · Cited by 159 · see citing works
Oertel, W. H., Stiasny‐Kolster, K., Bergtholdt, B., Hallström, Y., Albo, J., Leissner, L. C., Schindler, T. M., Koester, J., & Reess, J. (2006) · Movement Disorders · doi:10.1002/mds.21261 · Cited by 131 · see citing works
Geracioti, T. D., Orth, D. N., Ekhator, N. N., Blumenkopf, B., & Loosen, P. T. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.6.1317385 · Cited by 112 · see citing works
Circadian changes in CSF dopaminergic measures in restless legs syndrome
Earley, C. J., Hyland, Κ., & Allen, R. P. (2006) · Sleep Medicine · doi:10.1016/j.sleep.2005.09.006 · Cited by 101 · see citing works
Montplaisir, J. Y., Karrasch, J., Haan, J., & Volc, D. (2006) · Movement Disorders · doi:10.1002/mds.21050 · Cited by 97 · see citing works
Genetics of restless legs syndrome (RLS): State-of-the-art and future directions
Winkelmann, J., Polo, O., Provini, F., Nevšímalová, S., Kemlink, D., Šonka, K., Högl, B., Poewe, W. H., Stiasny‐Kolster, K., Oertel, W. H., et al. (2007) · Movement Disorders · doi:10.1002/mds.21587 · Cited by 80 · see citing works
Ferritin subunits in CSF are decreased in restless legs syndrome
Clardy, S. L., Earley, C. J., Allen, R. P., Beard, J. L., & Connor, J. R. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2005.06.011 · Cited by 77 · see citing works
Circadian Variation of the Effects of Immobility on Symptoms of Restless Legs Syndrome
Michaud, M., Dumont, M., Paquet, J., et al. (2005) · SLEEP · doi:10.1093/sleep/28.7.843 · Cited by 50 · see citing works
Hagan, M. M., Havel, P. J., Seeley, R. J., Woods, S. C., Ekhator, N. N., Baker, D. G., Hill, K. K., Wortman, M. D., Miller, A. H., Gingerich, R. L., et al. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6034 · Cited by 50 · see citing works
Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome.
Horiguchi, J., Yamashita, H., Mizuno, S., et al. (1999) · PubMed · Cited by 49 · see citing works
Continuous covariability of dopamine and serotonin metabolites in human cerebrospinal fluid
Geracioti, T. D., Keck, P. E., Ekhator, N. N., West, S. A., Baker, D. G., Hill, K. K., Bruce, A. B., & Wortman, M. D. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)90372-3 · Cited by 45 · see citing works
Neurobiology of Cerebrospinal Fluid: 1
Bradbury, M. (1981) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.5.463-c · Cited by 43 · see citing works
Hill, K. K., West, S. A., Ekhator, N. N., Bruce, A., Wortman, M. D., Baker, D. G., & Geracioti, T. D. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00778-8 · Cited by 35 · see citing works
CSF hypocretin-1 levels in restless legs syndrome
Stiasny‐Kolster, K., Mignot, E. J.-M., Ling, L., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000094196.50155.38 · Cited by 34 · see citing works
Aetiopathogenesis of restless legs syndrome
Zucconi, M., Manconi, M., & Ferini‐Strambi, L. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0737-9 · Cited by 18 · see citing works
Biochemical aids in the diagnosis of Parkinson's disease.
Chase, T. N., Eng, N., & Gordon, E. K. (1976) · PubMed · Cited by 14 · see citing works
Wszołek, Z. K., & Brown, L. (2006) · Movement Disorders · doi:10.1002/mds.21212 · Cited by 10 · see citing works
West, K. A., & Roos, B. E. (2007) · Confinia Neurologica · doi:10.1159/000103046 · Cited by 3 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Vanderstichele, H., Bibl, M., Engelborghs, S., Le Bastard, N., Lewczuk, P., Molinuevo, J. L., Parnetti, L., Perret‐Liaudet, A., Shaw, L. M., Teunissen, C., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.07.004 · Cited by 358 · see citing works
Circadian dysregulation in Parkinson's disease
Videnovic, A., & Golombek, D. (2017) · Neurobiology of Sleep and Circadian Rhythms · doi:10.1016/j.nbscr.2016.11.001 · Cited by 63 · see citing works
- Authors
- Poceta, J. S., Parsons, L., Engelland, S., & Kripke, D. F.
- Affiliations
- Scripps Research Institute (US)
- Corresponding author
- Poceta, J. Steven
- ORCID
- Kripke, Daniel F.
- Venue
- Sleep Medicine
- Publisher
- Elsevier BV
- Published
- 2009-01
- Volume
- 10
- Issue
- 1
- Pages
- 129-133
- ISSN
- 1389-9457 (ISSN-L)
- OpenAlex
- W2147880948
- Cited by
- 68
- References
- 27
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 7 · 2022: 1 · 2021: 1 · 2020: 3 · 2019: 4 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 5 · 2012: 6
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Sleep Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Alcohol Abuse and Alcoholism (R01AA014619)
- National Institute on Drug Abuse (R21DA019962)
- Topics
- Health Sciences › Medicine › Epidemiology › Restless Legs Syndrome Research
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cognitive Neuroscience › Sleep and Wakefulness Research
- Keywords
- restless legs syndrome, Parkinson's disease, circadian rhythm, cerebrospinal fluid, dopamine, homovanillic acid, dihydroxyphenylacetic acid, 5-hydroxyindoleacetic acid, orexin-A, monoamines
- MeSH terms
- Orexins, Aged, Chromatography, High Pressure Liquid, Circadian Rhythm, Dopamine, Feasibility Studies, Female, Homovanillic Acid, Humans, Hydroxyindoleacetic Acid, Male, Middle Aged, Neuropeptides, Parkinson Disease, Pilot Projects, Restless Legs Syndrome, 3,4-Dihydroxyphenylacetic Acid, Biogenic Monoamines, Intracellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review